COSM Key Statistics, Chart & Performance
The current stock price of COSM is 0.515 USD. In the past month the price increased by 4.91%. In the past year, price decreased by -26.32%.
COSM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 22.7 | 101.64B | ||
| COR | CENCORA INC | 21.19 | 65.74B | ||
| CAH | CARDINAL HEALTH INC | 23.09 | 48.88B | ||
| HSIC | HENRY SCHEIN INC | 15.94 | 9.04B | ||
| AHCO | ADAPTHEALTH CORP | 30.22 | 1.31B | ||
| OMI | OWENS & MINOR INC | 2.17 | 216.58M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 38.90M |
Related stock screener links
About COSM
Company Profile
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Company Info
COSMOS HEALTH INC
5 Agiou Georgiou, Pilea
Thessaloniki ILLINOIS GR
Employees: 149
Phone: 303125363102
COSMOS HEALTH INC / COSM FAQ
Can you describe the business of COSMOS HEALTH INC?
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
What is the stock price of COSMOS HEALTH INC today?
The current stock price of COSM is 0.515 USD. The price increased by 3.41% in the last trading session.
What is the dividend status of COSMOS HEALTH INC?
COSM does not pay a dividend.
What is the ChartMill rating of COSMOS HEALTH INC stock?
COSM has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is COSMOS HEALTH INC (COSM) stock traded?
COSM stock is listed on the Nasdaq exchange.
What sector and industry does COSMOS HEALTH INC belong to?
COSMOS HEALTH INC (COSM) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the outstanding short interest for COSMOS HEALTH INC?
The outstanding short interest for COSMOS HEALTH INC (COSM) is 0.53% of its float.
COSM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to COSM. When comparing the yearly performance of all stocks, COSM is a bad performer in the overall market: 91.16% of all stocks are doing better.
COSM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to COSM. COSM has a bad profitability rating. Also its financial health evaluation is rather negative.
COSM Financial Highlights
Over the last trailing twelve months COSM reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS increased by 68.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.68% | ||
| ROE | -80.15% | ||
| Debt/Equity | 0.55 |
COSM Forecast & Estimates
For the next year, analysts expect an EPS growth of 101.28% and a revenue growth 25% for COSM